Specialties
Reports that name this provider
- Clinical Trial Access in Malaysia
- Selected by Roche Pharmaceuticals as Asia-Pacific inaugural site for first-in-human global multicenter trial targeting Systemic Lupus Erythematosus in January 2024. Clinical Research Centre holds full NPRA Phase I accreditation (first in Malaysia), achieved after 20 years of development. Phase I ward includes specialist staff: pharmacists, nurses, medical officers, scientists. Active FIH pipeline includes Roche SLE immunosuppressant FIH (enrolled 2024), AstraZeneca first-in-class solid tumor FIH (2024), and three additional multinational-sponsored FIH oncology studies targeting solid tumors, non-small cell lung cancer, and prostate cancer. Roche conducted 33 late-phase trials at site since 2012, investing approximately RM190 million.
- ECT/TMS Availability in Malaysia
- Malaysia Neuropsychiatric Fellowship Training Programme site
- Other Traditional Medicine in Malaysia
- public hospital; integrated T&CM unit
- Palliative Sedation Availability in Malaysia
- Home-based palliative care programme running since 1994. Pioneered decentralised model of nurse-empowered community palliative care including medication facilitation.
- Stem Cell Transplant Quality in Malaysia
- Government MOH hospital; commenced BMT services in early 2025